Abstract:Objective: To enquire into the clinical significance and potential molecular mechanism of microRNA (miRNA)-196b-5p in hepatocellular carcinoma (HCC). Methods: Quantitative reverse transcription and polymerase chain reaction (qRT-PCR) were utilized to examine miR-196b-5p expression level in 67 HCC paraffin embedded tissues and corresponding adjacent tissues. Correlations of miR-196b-5p expression level with clinicopathological characteristics were analyzed in our study. The expression level and clinical significance of miR-196b-5p in HCC were also evaluated in The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) database. We made predictions of the target genes of miR-196b-5p by twelve online software and then selected genes predicted by at least 5 software. Subsequently, in order to obtain the potential target genes of miR-196b-5p, we overlapped the predicted target genes and down-regulated mRNAs in HCC based on TCGA database. Then, we performed the Gene Ontology (GO) and the Disease Ontology (DO) functional annotation, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis and Protein-Protein Interaction (PPI) network construction of those miR-196b-5p potential target genes. Results: Higher expression level of miR-196b-5p was seen in HCC tissues than in the corresponding adjacent tissues based on qRT-PCR (P = 0.0007). The expression level of miR-196b-5p was linked with tumor size (P = 0.03), tumor node (P = 0.024), vascular invasion (P = 0.029) and capsular invasion (P = 0.026) in HCC patients. Comprehensive meta-analysis of miR-196b-5p expression based on TCGA, GEO and qRT-PCR verified that higher expression level of miR-196b-5p was observed in HCC tissues than in normal control liver tissues (SMD = 0.56, 95%CI: 0.39-0.72, P (heterogeneity) = 0.275, I-2 = 18.3%). GO annotation revealed that the top terms in biological process, cellular component and molecular function were single-organism catabolic process, neuronal cell body and transmembrane receptor protein kinase activity, respectively. The most relevant disease in DO annotation was arteriosclerosis. The tryptophan metabolism pathway ranked first in KEGG pathway enrichment analysis. The PPI network showed that IGF1, FOXO1, AR and FOS were mostly likely to become the core genes of miR-196b-5p potential target genes, which however required further experiments for validation. Conclusion: The miR-196b-5p was observed to show higher expression in HCC tissues than in normal control liver tissues. Moreover, the miR-196b-5p expression level had correlations with the clinicopathological parameters such as vascular invasion of HCC, but the molecular mechanisms of miR-196b-5p in HCC still need further elucidation and verification.

Down-regulation of miR-26 a-5 p and its regulatory roles in hepatocellular carcinoma : an in silico analysis

Down-regulation of Mir-26A-5p in Hepatocellular Carcinoma: A Qrt-Pcr and Bioinformatics Study

Regulation of proliferation, angiogenesis and apoptosis in hepatocellular carcinoma by miR-26b-5p

Identification of the typical miRNAs and target genes in hepatocellular carcinoma.

Upregulated miR-18 a-5 p and its regulatory roles in hepatocellular carcinoma : a study based on bioinformatics analysis with miRNA-seq and miRNA-microarray data

Down‐regulation of Mir‐146a‐5p and Its Potential Targets in Hepatocellular Carcinoma Validated by a TCGA‐ and GEO‐based Study

MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway.

Down-Regulation And Clinical Role Of Mir-30a-5p In Hepatocellular Carcinoma: A Study Based On Public High-Throughput Datasets

MicroRNA-26a Inhibits Angiogenesis by Down-Regulating VEGFA Through the PIK3C2α/Akt/HIF-1α Pathway in Hepatocellular Carcinoma.

A miRNA-mediated attenuation of hepatocarcinogenesis in both hepatocytes and Kupffer cells

Clinical Significance of Microrna-196B-5p in Hepatocellular Carcinoma and Its Potential Molecular Mechanism

Downregulation of Mir-136-5p in Hepatocellular Carcinoma and Its Clinicopathological Significance

microRNA-26a suppresses recruitment of macrophages by down-regulating macrophage colony-stimulating factor expression through the PI3K/Akt pathway in hepatocellular carcinoma

Microrna-26a Suppresses Angiogenesis in Human Hepatocellular Carcinoma by Targeting Hepatocyte Growth Factor-Cmet Pathway

MiR-875-5p suppresses Gli1 to alter the hedgehog signaling pathway, which in turn has hepatocellular cancer-related tumor suppressing properties

Diagnostic Significance and Potential Function of Mir-338-5p in Hepatocellular Carcinoma: A Bioinformatics Study with Microarray and RNA Sequencing Data

Analysis of microarrays of miR-34a and its identification of prospective target gene signature in hepatocellular carcinoma

Investigation of the clinical significance and molecular mechanism of miR-21-5p in hepatocellular carcinoma: A systematic review based on 24 studies and bioinformatics investigation.

MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2

Microrna-26 a Induces a Mitochondrial Apoptosis Mediated by P 53 Through Targeting to Inhibit Mcl 1 in Human Hepatocellular Carcinoma

Promising significance of the association of miR-204-5p expression with clinicopathological features of hepatocellular carcinoma.